Category Archives: Fda

FDA Approves Two-In-One Diabetes Treatment For Type 2

By Brenda Neugent

The U.S. Food and Drug Administration recently approved a two-in-one diabetes treatment that combines two type 2 treatments.

Glyxambi combines empagliflozin, a sodium glucose cotransporter-2 inhibitor that blocks the absorption of excess glucose by the kidneys so …

Insulin Pens are Not for Sharing: Diabetes Health Editor’s Note

The FDA reminds us why sharing insulin pens may create long terms health concerns. While some people do save on costs when reusing and or sharing insulin pens, the possible long term complications are not worth the savings.

By Food …

FDA Approves Once-weekly Trulicity to Treat Type 2 Diabetes

The U.S. Food and Drug Administration recently approved Trulicity, a once-weekly injectable to treat adults with type 2 diabetes.

Also known as dulaglutide, Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps normalize blood sugar levels by encouraging the …

A Spoonful of Splenda

What color is sugar? For most people with diabetes, the colors pink, blue and yellow might come to mind. Many people often rely on the little colored packets of artificial sweeteners when managing their blood sugar or their weight. It …

Company to Launch Generic Test Strips

Those who skip critical blood glucose testing because of the price tag on a box of strips may soon get a break. The Charlotte, N.C.-based company UniStrip Technologies has launched a new generic blood glucose test strip, designed for use with …

Prodigy Diabetes Care Moves Forward After FDA Concludes Regulatory Action

CHARLOTTE, N.C., April 16, 2014 /PRNewswire/ — On April 10, 2014 the U.S. Food & Drug Administration (FDA) issued a “Closeout” letter to Prodigy Diabetes Care to formally conclude the regulatory action that resulted in a Warning Letter on February 22, …